Stocks · Health care · Biological Products, (No Diagnostic Substances)

Apogee Therapeutics, Inc.

APGE Clue Score20
United States Fiscal year ends December CIK 0001974640 Results filed 10 Aug 2026

What the insiders did Net selling

Insider
Date
Role
Action
Shares
Price
Amount
Carl Dambkowski
5 Aug 2026
Chief Medical Officer
Sold after exercise
5,500
$134.17
$737.94K
Carl Dambkowski
1 Jul 2026
Chief Medical Officer
Sold after exercise
5,500
$132.74
$730.07K
Carl Dambkowski
3 Jun 2026
Chief Medical Officer
Sold after exercise
5,500
$78.71
$432.91K
Carl Dambkowski
6 May 2026
Chief Medical Officer
Sold after exercise
1,800
$84.60
$152.28K
Carl Dambkowski
6 May 2026
Chief Medical Officer
Sold after exercise
3,700
$83.92
$310.50K
Carl Dambkowski
1 Apr 2026
Chief Medical Officer
Sold after exercise
100
$85.89
$8.59K
Carl Dambkowski
1 Apr 2026
Chief Medical Officer
Sold after exercise
2,702
$85.33
$230.56K
Carl Dambkowski
1 Apr 2026
Chief Medical Officer
Sold after exercise
2,698
$84.31
$227.47K
Carl Dambkowski
4 Mar 2026
Chief Medical Officer
Sold after exercise
200
$73.26
$14.65K
Carl Dambkowski
4 Mar 2026
Chief Medical Officer
Sold after exercise
2,075
$71.98
$149.36K
Carl Dambkowski
4 Mar 2026
Chief Medical Officer
Sold after exercise
3,225
$70.33
$226.81K
Carl Dambkowski
4 Feb 2026
Chief Medical Officer
Sold after exercise
200
$68.94
$13.79K
Carl Dambkowski
4 Feb 2026
Chief Medical Officer
Sold after exercise
100
$67.88
$6.79K
Carl Dambkowski
4 Feb 2026
Chief Medical Officer
Sold after exercise
1,299
$66.85
$86.84K
Carl Dambkowski
4 Feb 2026
Chief Medical Officer
Sold after exercise
1,420
$65.83
$93.48K
Carl Dambkowski
4 Feb 2026
Chief Medical Officer
Sold after exercise
2,481
$64.88
$160.97K
Carl Dambkowski
7 Jan 2026
Chief Medical Officer
Sold after exercise
100
$80.06
$8.01K
Carl Dambkowski
7 Jan 2026
Chief Medical Officer
Sold after exercise
826
$79.04
$65.29K
Carl Dambkowski
7 Jan 2026
Chief Medical Officer
Sold after exercise
14,820
$77.90
$1.15M
Carl Dambkowski
7 Jan 2026
Chief Medical Officer
Sold after exercise
2,954
$77.13
$227.84K

What was left out

Form 4 filings counted 56
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 4
Sales on a Rule 10b5-1 plan 57
Sales straight out of an exercise 20
Sales at will 1
Transactions with no price 0
Shares from compensation/vesting 3,716,799
History held since 17 Jul 2023